DES Channel

Page 1 2 3 4 5 6 7 8 9 10

FDA Approves EXCELLA III Trial of Elixir’s Desyne Nx Stent [News Item]
March/April 2013
Two-Year TWENTE Data Published [News Item]
March/April 2013
FDA Approves Longer Lengths of Medtronic’s Resolute Integrity Stent [News Item]
January/February 2013
European Labeling Update Approved for 1-Month DAPT With Medtronic’s Resolute Integrity Stent [News Item]
January/February 2013
Medtronic’s RESOLUTE Program Shows No Increased Safety Risk in Interrupting DAPT at 1 Month After Stent Implantation [News Item]
January/February 2013
Terumo’s Nobori Biolimus Stent Shows Equivalence to Everolimus Stent at 1 Year [News Item]
January/February 2013
Reva Initiates Enrollment in Trial of the ReZolve2 Bioresorbable Coronary Scaffold [News Item]
January/February 2013

Published Results Support Medtronic's Resolute Stent in Diabetes Patients [News Item]
January/February 2013
One-Year SPIRIT Small-Vessel Data Support Abbott Vascular’s Xience Nano [News Item]
September/October 2012
Pivotal Study Approved by FDA for Svelte’s Coronary Stent Integrated Delivery System [News Item]
September/October 2012
Medtronic Presents RESOLUTE Data for Small Vessels and Long Lesions [News Item]
September/October 2012
European Labeling Update Approved for 3-Month DAPT for Boston Scientific’s Promus Element and Promus Element Plus [News Item]
September/October 2012
Two-Year Results Presented for Boston Scientific’s PLATINUM Long Lesion Trial at TCT [News Item]
September/October 2012
Second-Generation DES Supported by ISAR-LEFT MAIN 2 Results at TCT [News Item]
September/October 2012